RECRUITING

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness

Conditions

Anxiety Disorders Psychotic Disorders Depressive Disorder Psychosocial Functioning

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study aims to develop a brief group-based treatment called Resilience Training for Teens, then to test how well it protects high school students with mild symptoms of depression, anxiety, or having unusual feelings from developing mental illnesses.

Official Title

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness

Quick Facts

Study Start:2024-03-22

Study Completion:2027-07-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05962879

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:14 Years to 19 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:CHILD, ADULT

Inclusion Criteria	Exclusion Criteria
* Currently enrolled in 9th through 12th grade and between the ages of 14 and 19 * Endorsed at least one psychotic experience * Provided contact information * Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18) * Have a parent or legal guardian who is able and willing to participate in a parent session * Competent and willing to provide written informed assent (if under the age of 18) or consent (if age 18 or older) * Able to communicate in English	* Currently prescribed psychotropic medication (not including medications for attention deficit/hyperactivity disorder), regardless of adherence * Currently obtaining psychotherapeutic intervention

Inclusion Criteria

Exclusion Criteria

* Currently enrolled in 9th through 12th grade and between the ages of 14 and 19
* Endorsed at least one psychotic experience
* Provided contact information
* Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18)
* Have a parent or legal guardian who is able and willing to participate in a parent session
* Competent and willing to provide written informed assent (if under the age of 18) or consent (if age 18 or older)
* Able to communicate in English

* Currently prescribed psychotropic medication (not including medications for attention deficit/hyperactivity disorder), regardless of adherence
* Currently obtaining psychotherapeutic intervention

Contacts and Locations

Study Contact

Nicole R DeTore, PhD

CONTACT

617-726-2065

ndetore@mgh.harvard.edu

Study Locations (Sites)

Massachusetts General Hospital

Boston, Massachusetts, 02114

United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-22

Study Completion Date2027-07-31

Study Record Updates

Study Start Date2024-03-22

Study Completion Date2027-07-31

Terms related to this study

Additional Relevant MeSH Terms

Anxiety Disorders
Psychotic Disorders
Depressive Disorder
Psychosocial Functioning